Patent details

EP2578585 Title: PURINONE DERIVATIVE AS BTK KINASE INHIBITOR

Basic Information

Publication number:
EP2578585
PCT Application Number:
PCT/JP/2011/062377
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117897546
PCT Publication Number:
WO/2011/152351
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
PURINONE DERIVATIVE AS BTK KINASE INHIBITOR
French Title of Invention:
DÉRIVÉ DE PURINONE EN TANT QU'INHIBITEUR DE BTK
German Title of Invention:
PURINONDERIVAT ALS BTK-KINASEINHIBITOR
SPC Number:

Dates

Filing date:
30/05/2011
Grant date:
20/07/2016
EP Publication Date:
20/07/2016
PCT Publication Date:
08/12/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/04/2013
EP B1 Publication Date:
20/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/05/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/05/2011
 
 

Name:
ONO Pharmaceutical Co. Ltd.
Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, Japan (JP)

Agent

Name:
MARKS & CLERK LLP
From:
01/09/2016
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
YOSHIZAWA Toshio
Address:
Japan (JP)

2

Name:
YAMAMOTO Shingo
Address:
Japan (JP)

Priority

Priority Number:
2010123727
Priority Date:
31/05/2010
Priority Country:
Japan (JP)

Classification

Main IPC Class:
C07D 473/34;

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56